Compare ADMA & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | DEI |
|---|---|---|
| Founded | 2004 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2012 | 2006 |
| Metric | ADMA | DEI |
|---|---|---|
| Price | $9.25 | $10.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 8 |
| Target Price | ★ $25.67 | $12.94 |
| AVG Volume (30 Days) | ★ 1.7M | 1.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 7.06% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | $42,219,783.00 | ★ $1,003,982,000.00 |
| Revenue This Year | $27.46 | $1.70 |
| Revenue Next Year | $22.11 | $2.35 |
| P/E Ratio | $27.00 | ★ N/A |
| Revenue Growth | ★ 43.85 | 1.77 |
| 52 Week Low | $7.21 | $9.04 |
| 52 Week High | $20.46 | $16.74 |
| Indicator | ADMA | DEI |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 28.34 |
| Support Level | $9.23 | $9.17 |
| Resistance Level | $10.24 | $12.68 |
| Average True Range (ATR) | 0.24 | 0.27 |
| MACD | -0.04 | -0.10 |
| Stochastic Oscillator | 26.71 | 1.92 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.